44 results
8-K
EX-10.1
ZIVO
ZIVO Bioscience, Inc.
6 Jul 23
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
4:24pm
expert” as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. The Company will maintain a system of internal
8-K
EX-1.1
t5orh6r
2 Jun 21
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
5:14pm
424B4
lg1ek
1 Jun 21
Prospectus supplement with pricing info
4:37pm
10-K/A
5474xmaujv4l8dcp9i5
30 Apr 21
Annual report (amended)
11:52am
8-K
EX-10.1
3pn1 4zo6ij9
7 Jan 21
Zivo Bioscience Names Keith R. Marchiando As Chief Financial Officer
5:02pm
S-1
EX-1.1
bs31h40fp6z18w5rauml
9 Dec 20
IPO registration
3:30pm
DEFR14A
96aagvzh7ifgh 3o
19 Oct 20
Revised proxy
4:16pm